Literature DB >> 33837464

Prognostic value of systemic ımmune ınflammation ındex in patients with laryngeal cancer.

Ebru Atasever Akkas1, Birsen Yucel2.   

Abstract

PURPOSE: This study aimed to investigate the relationship between the neutrophil-to-lymphocyte ratio (NLR), the platelet-to-lymphocyte ratio (PLR), and the systemic immune-inflammation index (SII) with the clinical and pathological parameters of 118 laryngeal cancer patients, as well as their effects on the survival of the disease.
METHODS: For the calculation of SII, PLR, and NLR, hemogram tests were conducted before treatment. Receiver-operating characteristic (ROC) analysis was used to calculate the cut-off value of SII, NLR, and PLR for overall survival (OS) and disease-free survival (DFS).
RESULTS: A statistically significant relationship was found between SII and lymphovascular invasion and between NLR and local recurrence, and lymphovascular invasion. In a univariate analysis, SII (p < 0.001) and NLR (p = 0.001) for OS and SII (p < 0.001), PLR (p = 0.043), and NLR (p < 0.001) for DFS were detected as prognostic factors. In a multivariate analysis for OS, SII (HR = 10.54, 95% CI 1.28-86.77; p = 0.029) and extracapsular extension (HR = 3.08, 95% CI 1.15-8.21; p = 0.024) were identified as independent prognostic factors. In a multivariate analysis for DFS, only an extracapsular extension presence (HR = 3.32, 95% CI 1.37-8.08; p = 0.008) was detected as an independent prognostic factor.
CONCLUSION: In laryngeal cancer, high SII values were determined as poor independent prognostic factors for OS. High SII, NLR, and PRL have been identified as poor prognostic factors in DFS. A correlation was found between NLR and local recurrence, and lymphovascular invasion and between SII with lymphovascular invasion positivity.

Entities:  

Keywords:  Laryngeal cancer; Neutrophil-to-lymphocyte ratio; Platelet-to-lymphocyte ratio; Systemic immune-inflammation index

Mesh:

Year:  2021        PMID: 33837464     DOI: 10.1007/s00405-021-06798-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  3 in total

1.  TruScreen detection of cervical tissues for high-risk human papillomavirus-infected women during the COVID-19 pandemic.

Authors:  Ziyao Wang; YaNan Kang; FuRong Yu; Feng-Hui Zhong; Kangni Huang; Xuan Zhou; Yunrong Tang; Yu Zhang; Yu-Ligh Liou; Yan Ma
Journal:  Future Oncol       Date:  2020-12-17       Impact factor: 3.404

2.  A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma.

Authors:  Lu Wang; Cong Wang; Jiangfeng Wang; Xiaochen Huang; Yufeng Cheng
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-10       Impact factor: 4.553

3.  Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis.

Authors:  Yiting Geng; Yingjie Shao; Danxia Zhu; Xiao Zheng; Qi Zhou; Wenjie Zhou; Xuefeng Ni; Changping Wu; Jingting Jiang
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

  3 in total
  5 in total

1.  NLR, PLR, LMR and MWR as diagnostic and prognostic markers for laryngeal carcinoma.

Authors:  Pingdong Li; Haiyang Li; Shuo Ding; Jing Zhou
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

2.  Role of the Systemic Immune-Inflammation Index in Patients with Metastatic Renal Cell Carcinoma Treated with First-Line Ipilimumab plus Nivolumab.

Authors:  Viktoria Stühler; Lisa Herrmann; Steffen Rausch; Arnulf Stenzl; Jens Bedke
Journal:  Cancers (Basel)       Date:  2022-06-16       Impact factor: 6.575

3.  Systemic Immun e-Inflammation Index as a Predictor for Head and Neck Cancer Prognosis: A Meta-Analysis.

Authors:  Yun-Ting Wang; Liang-Tseng Kuo; Hsu-Huei Weng; Cheng-Ming Hsu; Ming-Shao Tsai; Geng-He Chang; Yi-Chan Lee; Ethan I Huang; Yao-Te Tsai
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

Review 4.  The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment.

Authors:  Dolores Aguilar-Cazares; Rodolfo Chavez-Dominguez; Mario Marroquin-Muciño; Mario Perez-Medina; Jesus J Benito-Lopez; Angel Camarena; Uriel Rumbo-Nava; Jose S Lopez-Gonzalez
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-22       Impact factor: 6.055

5.  Prognostic and Clinicopathological Significance of the Systemic Immune-Inflammation Index in Patients With Renal Cell Carcinoma: A Meta-Analysis.

Authors:  Mingyu Jin; Shaoying Yuan; Yiming Yuan; Luqi Yi
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.